Why Cellectis Stock Is Trading Higher Today

benzinga.com/markets/biotech/25/11/48959138/why-cellectis-stock-is-trading-higher-today

Cellectis A/S (NASDAQ:CLLS) on Wednesday published an article in Nature Communications establishing circular single-stranded DNA (CssDNA) as a highly efficient non-viral DNA donor template for gene insertion in hematopoietic stem and progenitor cells (HSPCs).
HSPCs are rare,…

This story appeared on benzinga.com, 2025-11-19 19:12:50.
The Entire Business World on a Single Page. Free to Use →